DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Park YH, Kim TY, Kim GM. et al.
A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15–10, NCT02592746).
J Clin Oncol 2019;
37 (Suppl.) Abstr.. 1007
We do not assume any responsibility for the contents of the web pages of other providers.